Brief: HBM Portfolio Company Longboard Pharmaceuticals Raises $80 Million In IPO
March 15 (Reuters) - HBM HEALTHCARE INVESTMENTS AG HBMN.S :
* SUCCESSFUL DEBUT ON THE STOCK EXCHANGE FOR HBM PORTFOLIO
COMPANY
LONGBOARD PHARMACEUTICALS
* LONGBOARD PHARMACEUTICALS RAISED USD 80 MILLION IN NEW
CAPITAL
BY ISSUING 5 MILLION SHARES AT A PRICE OF USD 16.00 EACH
Source text for Eikon: ID:nEQ6jqkzJa
Further company coverage: HBMN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics